DL 111-IT

Known as: DL111-IT 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2005
01219852005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
AIM To evaluate the antiproliferative activity of contragestazol (DL111-IT) on the human prostate cancer cell line PC3 in vitro… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2003
2003
This study evaluated the effectiveness and acute toxicity of DL111-IT combined with mifepristone (RU486) and misoprostol (MISO… (More)
Is this relevant?
2003
2003
An analytical method was developed for determining diphenytriazol and its related impurities in oil injection by using RP-HPLC… (More)
Is this relevant?
2001
2001
DL111-IT, a non-hormonal contragestional agent, revealed synergistic effects in combination with mifepristone (RU486) in some… (More)
Is this relevant?
2000
2000
The effectiveness of DL111-IT and RU486 given alone and in combination for terminating early pregnancy was tested in the rat… (More)
Is this relevant?
2000
2000
The objectives of this study were to determine the synergistic effects of DL111-IT in combination with mifepristone (RU486) on… (More)
Is this relevant?
1999
1999
The present studies were conducted to evaluate the effects of DL111-IT [3-(2-ethyl phenyl)-5-(3-methoxy phenyl)-1H-1,2,4 triazol… (More)
Is this relevant?
1997
1997
AIM To study the influence of DL111-IT on progesterone biosynthesis of cultured luteal cells (LC). METHODS LC viability was… (More)
Is this relevant?
1996
1996
AIM To clarify the role of DL111-IT when combined with mifepristone (Mif) on termination of early pregnancy. METHODS… (More)
Is this relevant?
1985
1985
The immunosuppressive properties of the non-hormonal contragestional agent 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4… (More)
Is this relevant?